Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

Within 2 hours of acetaminophen overdose, what is the antidote and initial decision rule for treatment?

The essential idea here is that acetaminophen overdose is treated with N-acetylcysteine, and the decision to start treatment is guided by a timing-based risk assessment using the Rumack-Matthew nomogram for a single acute ingestion within 24 hours with a detectable acetaminophen level. N-acetylcysteine works by replenishing glutathione stores and enabling detoxification of the harmful metabolite NAPQI, which is what drives hepatotoxicity after overdose. Starting NAC early markedly reduces the risk of liver injury, and the nomogram helps you decide who actually needs ongoing treatment. In practice, you obtain an acetaminophen concentration and note the time since ingestion. If the presentation is within 24 hours and the level is detectable, you plot the value on the Rumack-Matthew nomogram. If the plotted point sits above the treatment line, NAC should be started and continued according to protocol; if it sits below, the risk is low and NAC may not be required. The nomogram is not applicable for chronic overdose, multiple ingestions, or unknown timing, in which case treatment decisions rely on elevated liver enzymes, signs of hepatotoxicity, or high-risk history rather than the nomogram alone. Activated charcoal can reduce absorption if given very early (within about an hour), but it is not the antidote and does not replace the need for NAC. Treating only based on symptoms or assuming no treatment is needed is incorrect given the risk of delayed hepatotoxicity. Within this scenario, the best approach is to administer N-acetylcysteine and use the nomogram to guide ongoing treatment decisions based on acetaminophen level and timing.

The essential idea here is that acetaminophen overdose is treated with N-acetylcysteine, and the decision to start treatment is guided by a timing-based risk assessment using the Rumack-Matthew nomogram for a single acute ingestion within 24 hours with a detectable acetaminophen level. N-acetylcysteine works by replenishing glutathione stores and enabling detoxification of the harmful metabolite NAPQI, which is what drives hepatotoxicity after overdose. Starting NAC early markedly reduces the risk of liver injury, and the nomogram helps you decide who actually needs ongoing treatment.

In practice, you obtain an acetaminophen concentration and note the time since ingestion. If the presentation is within 24 hours and the level is detectable, you plot the value on the Rumack-Matthew nomogram. If the plotted point sits above the treatment line, NAC should be started and continued according to protocol; if it sits below, the risk is low and NAC may not be required. The nomogram is not applicable for chronic overdose, multiple ingestions, or unknown timing, in which case treatment decisions rely on elevated liver enzymes, signs of hepatotoxicity, or high-risk history rather than the nomogram alone.

Activated charcoal can reduce absorption if given very early (within about an hour), but it is not the antidote and does not replace the need for NAC. Treating only based on symptoms or assuming no treatment is needed is incorrect given the risk of delayed hepatotoxicity. Within this scenario, the best approach is to administer N-acetylcysteine and use the nomogram to guide ongoing treatment decisions based on acetaminophen level and timing.